Recall Weekly
Moderate riskFDA DrugClass II

Teva metoprolol succinate tablets recalled for failed dissolution

Teva Pharmaceuticals is recalling specific batches of Metoprolol Succinate Extended-Release 100 mg tablets because they may not dissolve properly in the body. This means the medication may not work as intended. The recall affects bottles with lot numbers ending in J251 or J252 and expiration dates of 12/2026.

From the FDA notice · Read the official notice ↗ · All Teva recalls

What to do

  1. Check your Metoprolol bottle for lot number and expiration date against the recall list
  2. Contact your pharmacy or doctor if you have an affected batch—do not stop taking your medication without medical guidance
  3. Your pharmacist can provide a replacement or alternative blood pressure medication
Official notice ↗

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000 tablets bottles (NDC: 45963-677-96), Teva Pharmaceuticals, Parsippany, NJ 07054.
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 4 products — see all of them.

Details

Units affected
7,448 bottles
Illnesses reported
None reported
Manufactured in
400 Interpace Pkwy Bldg A, N/A, Parsippany, NJ, United States
Classification
Class II
Recall number
D-0356-2026

In the FDA's words

Description
Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000 tablets bottles (NDC: 45963-677-96), Teva Pharmaceuticals, Parsippany, NJ 07054. Failed Dissolution Specifications Lot#: a) 0718J251, 0729J251, 0730J251, Exp.: 12/2026; b) 0718J252, 0729J252, 0730J252, Exp.: 12/2026. Distribution: Nationwide Affected quantity: 7,448 bottles
Hazard
Failed Dissolution Specifications

4 products in this recall

Teva metoprolol succinate tablets recalled for dissolution failure

Teva is recalling four strengths of metoprolol succinate extended-release tablets (25 mg, 50 mg, 100 mg and 200 mg), sold in 100- and 1,000-tablet bottles. The tablets did not meet the required dissolution specification, which means they may not release the medicine at the expected rate. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

More from Teva

See all

Related topics

PotencyDrugsSold nationwideMore from FDA Drug